The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Costs of asthma are correlated with severity: a 1-yr prospective study
Open accessAbstract
Asthma prevalence is increasing and asthma-related costs are likely to increase, but few studies have analysed the relationship of asthma costs and severity. The impact of severity on costs was quantified in a cohort of 318 asthmatic patients followed up prospectively for 1 yr. Patients presenting with a broad range of severity of the disease (intermittent, mild persistent, moderate persistent, severe persistent) were recruited by chest physicians throughout France and treated for 1 yr according to customary clinical practice and following international guidelines. Severity, direct and indirect costs, and quality of life (QoL) were assessed. A multivariate analysis was conducted to relate factors contributing to the costs measured. Mean direct costs for goods and services excluding hospitalization, numbers of consultations, supplementary examinations, and the use and cost of bronchodilators and corticosteroids, indirect costs of days lost from work, and adverse QoL parameters all increased significantly with increasing severity. This also applied to mean age, body weight, asthma duration, depression of forced expiratory volume in one second, and inhaled corticosteroid posology in the 234 patients completing the study. There was a significant relationship (r=0.614, p<0.001) between direct costs (hospitalization and cures were excluded) and three domains of the QoL questionnaire (mobility, pain and energy). Overall costs of asthma (including individual direct costs, indirect costs, and intangible quality of life costs) are clearly related to severity. This is the first study in asthma to combine rigorous independent classification of grades of severity in statistically valid numbers of patients of grades receiving “real-world” treatment and followed-up prospectively for 1 yr. It allowed severity to be accurately related to direct, indirect and intangible costs of asthma. Quality of life explained a significant part of these costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eosinophilic Inflammation in Asthma
Bousquet, J., Chanez, P., Lacoste, J. Y., Barnéon, G., Ghavanian, N., Enander, I., Venge, P., Ahlstedt, S., Simony-Lafontaine, J., Godard, P., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010113231505 · Cited by 2,499
Self-citationAn Economic Evaluation of Asthma in the United States
Weiss, K. B., Gergen, P. J., & Hodgson, T. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261304 · Cited by 995
Guidelines for the management of chronic obstructive pulmonary disease
Buist, A. S. (2002) · Respiratory Medicine · doi:10.1016/s0954-6111(02)80029-4 · Cited by 607
Crapo, R. O. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407073310107 · Cited by 576
A National Estimate of the Economic Costs of Asthma
SMITH, D. H., MALONE, D. C., LAWSON, K. A., OKAMOTO, L. J., BATTISTA, C., & SAUNDERS, W. B. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.3.9611072 · Cited by 562
Barnes, P., Jonsson, B., & Klim, J. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09040636 · Cited by 434
Bentley, A. M., Menz, G., Storz, C., Robinson, D. S., Bradley, B., Jeffery, P. K., Durham, S. R., & Kay, A. B. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.2.500 · Cited by 407
Costs of asthma according to the degree of severity
Serra-Batlles, J., Plaza, V, Morejon, E., Comella, A., & Brugues, J. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12061322 · Cited by 387
Trends in the cost of illness for asthma in the United States, 1985-1994
Weiss, K. B., Sullivan, S. D., & Lyttle, C. S. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.109426 · Cited by 366
Inhaled corticosteroid use and bone-mineral density in patients with asthma
Wong, C. A., Walsh, L. J., Smith, C. J., Wisniewski, A. F., Lewis, S. A., Hubbard, R., Cawte, S., Green, D. J., Pringle, M., & Tattersfield, A. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02138-3 · Cited by 362
Bentley, A. M. (1992) · Medical Entomology and Zoology · Cited by 282
Upton, M. N. (2000) · BMJ · doi:10.1136/bmj.321.7253.88 · Cited by 276
Heterogeneity of Bronchial Asthma: Sub‐populations – or Different Stages of the Disease
Aas, K. (1981) · Allergy · doi:10.1111/j.1398-9995.1981.tb01818.x · Cited by 228
Enhanced alveolar cell luminol-dependent chemiluminescence in asthma
Cluzel, M., Damon, M., Chanez, P., Bousquet, J., de Paulet, A. C., Michel, F. B., & Godard, P. (1987) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(87)90129-1 · Cited by 211
Self-citationAsthma Guidelines: An Assessment of Physician Understanding and Practice
DOERSCHUG, K. C., PETERSON, M. W., DAYTON, C. S., & KLINE, J. N. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.6.9809051 · Cited by 174
Compliance With Peak Expiratory Flow Monitoring in Home Management of Asthma
Côté, J., Cartier, A., Malo, J., Rouleau, M., & Boulet, L. (1998) · CHEST Journal · doi:10.1378/chest.113.4.968 · Cited by 144
Monitoring the patient with asthma: An evidence-based approach
Gibson, P. G. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.108307 · Cited by 97
The economic burden of asthma: direct and indirect costs in Switzerland
Szucs, T. D., Anderhub, H. P., & Rutishauser, M. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13b10.x · Cited by 96
JACOBSON, L., Hertzman, P., Löfdahl, C., Skoogh, B., & Lindgren, B. (2000) · Respiratory Medicine · doi:10.1053/rmed.1999.0733 · Cited by 95
Hill, R. A. (1976) · University Microfilms International eBooks · Cited by 75
Quality of Life and Economic Features in Elderly Asthmatics
Plaza, V., Serra-Batllés, J., Ferrer, M., & Morejón, E. (2000) · Respiration · doi:10.1159/000029465 · Cited by 67
Mellis, C. M., Peat, J. K., & Woolcock, A. J. (1993) · PharmacoEconomics · doi:10.2165/00019053-199303030-00004 · Cited by 64
Groban, M. D., Evans, R. M., Edgren, B., Butt, L. T., De Stefano, A., Fernandes, D. J., & Buchner, D. A. (1998) · Disease Management & Health Outcomes · doi:10.2165/00115677-199804020-00003 · Cited by 19
Watkins, K. D. (1999) · Journal of Medical Systems · doi:10.1023/a:1020518125649 · Cited by 8
Cited by
Pavord, I. D., Korn, S., Howarth, P., Bleecker, E. R., Buhl, R., Keene, O. N., Ortega, H., & Chanez, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60988-x · Cited by 2,221
Self-citationDupilumab in Persistent Asthma with Elevated Eosinophil Levels
Wenzel, S., Ford, L., Pearlman, D., Spector, S., Sher, L., Skobieranda, F., Wang, L., Kirkesseli, S., Rocklin, R., Bock, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304048 · Cited by 1,320
Braman, S. S. (2006) · Chest · doi:10.1378/chest.130.1_suppl.4s · Cited by 1,176
Moore, W. C., Bleecker, E. R., Curran-Everett, D., Erzurum, S. C., Ameredes, B. T., Bacharier, L., Calhoun, W. J., Castro, M., Chung, K. F., Clark, M. P., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.11.639 · Cited by 929
Asthma costs and social impact
Nunes, C., Pereira, A. M., & Morais-Almeida, M. (2017) · Asthma Research and Practice · doi:10.1186/s40733-016-0029-3 · Cited by 752
Metadata
- Authors
- Godard, P., Chanez, P., Siraudin, L., Nicoloyannis, N., & Duru, G.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2001-01-01
- Volume
- 19
- Issue
- 1
- Pages
- 61-67
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2163779250
- Cited by
- 331
- References
- 25
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.